Susquehanna International Group
IART icon

Susquehanna International Group’s Integra LifeSciences IART Stock Holding History

Susquehanna International Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,100
Closed -$202K – 12637
2024
Q3 		$202K Sell
11,100
-2,300
-17% -$53.3K ﹤0.01% 10457
2024
Q2 		$390K Buy
13,400
+6,700
+100% +$199K ﹤0.01% 8859
2024
Q1 		$238K Buy
+6,700
New +$268K ﹤0.01% 10228
2023
Q2 		– Sell
-14,100
Closed -$809K – 12532
2023
Q1 		$809K Sell
14,100
-22,400
-61% -$1.26M ﹤0.01% 7380
2022
Q4 		$2.05M Buy
36,500
+27,400
+301% +$1.39M ﹤0.01% 4667
2022
Q3 		$385K Sell
9,100
-16,400
-64% -$840K ﹤0.01% 9157
2022
Q2 		$1.38M Buy
+25,500
New +$1.53M ﹤0.01% 5752
2022
Q1 		– Sell
-22,400
Closed -$1.5M – 13431
2021
Q4 		$1.5M Buy
+22,400
New +$1.52M ﹤0.01% 6209
2021
Q2 		– Sell
-6,400
Closed -$442K – 12859
2021
Q1 		$442K Sell
6,400
-13,300
-68% -$901K ﹤0.01% 9760
2020
Q4 		$1.28M Buy
+19,700
New +$1.06M ﹤0.01% 6101
2020
Q3 		– Sell
-10,600
Closed -$498K – 10793
2020
Q2 		$498K Buy
+10,600
New +$521K ﹤0.01% 7364
2019
Q2 		– Sell
-22,000
Closed -$1.23M – 10481
2019
Q1 		$1.23M Buy
+22,000
New +$1.12M ﹤0.01% 4624
2017
Q2 		– Sell
-45,600
Closed -$1.92M – 9448
2017
Q1 		$1.92M Buy
45,600
+11,000
+32% +$470K ﹤0.01% 3810
2016
Q4 		$1.48M Buy
+34,600
New +$1.41M ﹤0.01% 4689
2014
Q4 		– Sell
-13,456
Closed -$273K – 9817
2014
Q3 		$273K Sell
13,456
-16,146
-55% -$321K ﹤0.01% 8161
2014
Q2 		$569K Buy
+29,602
New +$552K ﹤0.01% 7220
2014
Q1 		– Sell
-12,966
Closed -$253K – 9115
2013
Q4 		$253K Buy
+12,966
New +$238K ﹤0.01% 7859

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Susquehanna International Group's IART Position: Q2 2026 in Review

Susquehanna International Group increased its Integra LifeSciences (IART) stake by 29% in Q2 2026, buying an estimated $103K and bringing the position to 33,095 shares worth $594K. The position accounts for ﹤0.01% of the portfolio, ranked #9499.

Susquehanna International Group first reported a position in IART in Q2 2013 and has held it in 40 quarters since. The position peaked at $12.2M in Q2 2018. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Susquehanna International Group held 33,095 shares of Integra LifeSciences worth $594K as of Q2 2026.
  • Susquehanna International Group bought 7,350 Integra LifeSciences shares in Q2 2026, an estimated $103K.
  • Integra LifeSciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #9499 holding.
  • Susquehanna International Group first reported a position in Integra LifeSciences in Q2 2013 and has held it in 40 quarters since.
  • Susquehanna International Group's Integra LifeSciences position peaked at $12.2M in Q2 2018.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.